A Paradigm Shift in the Management of Thyroid Eye Disease How Teprotumumab Has Changed the Therapeutic Interface

Authors: Kossler AL, Douglas R, Cockerham K. Ugradar S
Publication date: 1 March 2022
Publisher: Lippincott, Williams & Wilkins

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Ezid

redirect

Last time updated on 10/03/2023